Display Settings:

Format

Send to:

Choose Destination
Cell. 2011 Jul 22;146(2):247-61. doi: 10.1016/j.cell.2011.06.013.

FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism.

Author information

  • 1Laboratory of Molecular Neuro-Oncology, The Rockefeller University, New York, NY 10065, USA. darneje@rockefeller.edu

Abstract

FMRP loss of function causes Fragile X syndrome (FXS) and autistic features. FMRP is a polyribosome-associated neuronal RNA-binding protein, suggesting that it plays a key role in regulating neuronal translation, but there has been little consensus regarding either its RNA targets or mechanism of action. Here, we use high-throughput sequencing of RNAs isolated by crosslinking immunoprecipitation (HITS-CLIP) to identify FMRP interactions with mouse brain polyribosomal mRNAs. FMRP interacts with the coding region of transcripts encoding pre- and postsynaptic proteins and transcripts implicated in autism spectrum disorders (ASD). We developed a brain polyribosome-programmed translation system, revealing that FMRP reversibly stalls ribosomes specifically on its target mRNAs. Our results suggest that loss of a translational brake on the synthesis of a subset of synaptic proteins contributes to FXS. In addition, they provide insight into the molecular basis of the cognitive and allied defects in FXS and ASD and suggest multiple targets for clinical intervention.

Copyright © 2011 Elsevier Inc. All rights reserved.

PMID:
21784246
[PubMed - indexed for MEDLINE]
PMCID:
PMC3232425
Free PMC Article

Images from this publication.See all images (7)Free text

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk